My research interests focus on the roles mitochondria play in aspects of eukaryotic life, ranging from their origin, metabolism, biogenesis and role they play in cell death pathways. These are interrogated using biochemical, molecular biology, genetic and cell biology techniques. I incorporate these interests into classes I teach to provide an understanding of practical techniques and also the current literature in the field. I studied biochemistry at the University of Leeds, with an industrial placement at Astra Charnwood, followed by a PhD at the University of Bristol, supervised by Professor Andrew Halestrap, to characterise the molecular composition of the mitochondrial permeability transition pore, with support from MitoKor. My post-doctoral training on the mitochondrial pathway of apoptosis supervised by Dr Doug Green was at the La Jolla Institute of Allergy and Immunology in San Diego, California and St Jude Children's Research Hospital in Memphis, Tennessee. I then was an associate research scientist working in the laboratory of Professor Alexander Tzagoloff at Columbia University in New York to study biogenesis of mitochondrial cytochrome c oxidase in budding yeast, Saccharomyces cerevisiae. I held independent positions as assistant professor at the New York Institute of Technology in New York and Staffordshire University in Stoke-on-Trent where I continued my research and taught subjects related to biochemistry, cell biology, genetics and molecular biology. I am now a senior lecturer in biotechnology at Liverpool John Moores University.  I am a strong supporter of scientific communications and outreach to disseminate scientific developments and knowledge to a broader audience with the goal of increasing the general support of the scientific process. I also direct Biomed News, a free biomedical research literature discovery platform that uses machine learning.

'FEBS Communications' posts general items from the FEBS Network Team as well as news on FEBS events and other activities.

I'm a PhD student currently studying aging with repurposed drugs. My model organism of interest is C. elegans.   I am deep-diving into topics of proteostasis, aging and drug repurposing.  Connect with me to explore more of these topics. 

MSc in Bacterial Physiology and PhD in Protein Biochemistry Professor (Associate) at Akdeniz University Structural and functional analysis of rat prolactin receptor gene. Rat prolactin receptor and isoforms in liver and kidney. Non-genotoxic toxicity and tumorigenesis mechanisms of ochratoxin A (OTA) in vivo and in vitro. The role of testosterone and estrogen in OTA toxicity. The receptor mediated OTA toxicity and tumorigenesis in rat kidney. Ochratoxins Prolactin Receptors Estrogen Antagonists Estrogen Receptor Testosterone Androgen Receptors Nonsteroidal Anti-Androgens Ovariectomy Castration mRNA Expression Renal Pathology Renal Cancer Targeted Drug Delivery Toxicity Endocrine Disruption Reproductive Toxicology Estrogens Cancer Biology Androgens Steroids Toxicity Studies Native PAGE Endocrine Disruptors Environmental Toxicology Animal Physiology Encapsulation Cancer Research Nanoparticles Microbiology Biotechnology Proteins Protein Stability Ions Mycotoxins Cancer Cell Biology Fluorescence Spectroscopy Site-Directed Mutagenesis Wistar Rats Protein Folding Circular Dichroism Protein Conformation Cell Culture Molecular Endocrinology Neuroendocrinology Biomarkers PCR Protein Purification Reproductive Endocrinology Protein Structure Protein-Protein Interaction

The FEBS Junior Section is organised by students and young researchers from some FEBS Constituent Societies. They develop joint activities, such as online talks and other events, and share resources, as well as open doors for young European scientists to opportunities outside their home countries by providing the relevant contacts and fostering communication within the network.

Subham Preetam is the founder & chief executive officer of India-based startup company N BASE (Nano-Bio Advanced Sustainable Engineering). He is a passionate researcher in the fields of nanotechnology, biomedical engineering, and biorobotics research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals.